Heartland Advisors Inc. Invests $8.95 Million in Molina Healthcare, Inc $MOH

Heartland Advisors Inc. acquired a new stake in Molina Healthcare, Inc (NYSE:MOH) during the 2nd quarter, HoldingsChannel.com reports. The fund acquired 39,140 shares of the company’s stock, valued at approximately $8,951,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. BlackRock Inc. purchased a new stake in Molina Healthcare during the 2nd quarter worth about $1,503,052,000. AQR Capital Management LLC boosted its stake in shares of Molina Healthcare by 217.0% in the 3rd quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock valued at $561,475,000 after buying an additional 2,008,458 shares during the period. 8 Knots Management LLC purchased a new position in shares of Molina Healthcare in the 4th quarter valued at about $198,942,000. Maverick Capital Ltd. acquired a new position in shares of Molina Healthcare during the first quarter worth about $86,081,000. Finally, Madison Avenue Partners LP acquired a new position in shares of Molina Healthcare during the fourth quarter worth about $110,003,000. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

MOH has been the topic of several analyst reports. Truist Financial reduced their target price on shares of Molina Healthcare from $250.00 to $225.00 and set a “hold” rating on the stock in a report on Friday, July 24th. UBS Group increased their price objective on shares of Molina Healthcare from $180.00 to $202.00 and gave the company a “neutral” rating in a research report on Friday, May 22nd. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $129.00 price objective on shares of Molina Healthcare in a research report on Friday, April 24th. Zacks Research raised shares of Molina Healthcare from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 23rd. Finally, Robert W. Baird boosted their target price on shares of Molina Healthcare from $124.00 to $163.00 and gave the stock a “neutral” rating in a research note on Monday, May 11th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, eleven have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $202.44.

Molina Healthcare Stock Up 1.9%

MOH stock opened at $200.63 on Friday. The stock has a market cap of $10.47 billion, a P/E ratio of -1,114.55, a PEG ratio of 28.22 and a beta of 0.75. The company has a current ratio of 1.68, a quick ratio of 1.68 and a debt-to-equity ratio of 0.95. Molina Healthcare, Inc has a twelve month low of $121.06 and a twelve month high of $244.89. The company’s 50 day moving average is $211.25 and its two-hundred day moving average is $178.58.

Molina Healthcare (NYSE:MOH) last issued its earnings results on Wednesday, July 22nd. The company reported $1.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.12. The business had revenue of $10.87 billion during the quarter, compared to analysts’ expectations of $10.83 billion. Molina Healthcare had a negative net margin of 0.02% and a positive return on equity of 3.73%. The company’s revenue for the quarter was down 4.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $5.48 EPS. Research analysts expect that Molina Healthcare, Inc will post 5.29 earnings per share for the current fiscal year.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.